- Type / Class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 6,494,302
- Share change
- +1,475,079
- Total reported value
- $46,629,314
- Price per share
- $7.18
- Number of holders
- 56
- Value change
- +$11,145,137
- Number of buys
- 38
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 48115J109?
CUSIP 48115J109 identifies DERM - Journey Medical Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 48115J109:
Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
8%
|
1,854,596
|
$14,020,746 | $0 | 31 Mar 2025 | |
| Fortress Biotech, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,860,467
|
$11,735,820 | — | 12 May 2022 | |
| WASATCH ADVISORS LP |
13F
|
Company |
4.4%
|
930,603
|
$5,490,558 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
372,261
|
$2,196,340 | — | 31 Mar 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
1.6%
|
338,050
|
$1,994,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
238,000
|
$1,404,200 | — | 31 Mar 2025 | |
| Ernest Robert de Paolantonio |
3/4/5
|
Officer |
—
class O/S missing
|
259,907
|
$1,356,715 | — | 04 Oct 2022 | |
| AMERICAN FINANCIAL GROUP INC |
13F
|
Company |
0.84%
|
180,000
|
$1,062,000 | — | 31 Mar 2025 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.82%
|
174,379
|
$1,028,836 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
113,741
|
$671,232 | — | 31 Mar 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.48%
|
103,153
|
$608,603 | — | 31 Mar 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.32%
|
69,323
|
$409,006 | — | 31 Mar 2025 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.3%
|
63,280
|
$373,352 | — | 31 Mar 2025 | |
| Jeffrey Paley |
3/4/5
|
Director |
—
class O/S missing
|
70,727
|
$369,195 | — | 28 Nov 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.27%
|
57,339
|
$338,300 | — | 31 Mar 2025 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.27%
|
56,850
|
$335,415 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
53,234
|
$314,082 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.23%
|
49,259
|
$290,628 | — | 31 Mar 2025 | |
| Atria Investments, Inc |
13F
|
Company |
0.21%
|
44,659
|
$263,488 | — | 31 Mar 2025 | |
| Gladstone Institutional Advisory LLC |
13F
|
Company |
0.17%
|
36,854
|
$217,439 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
28,953
|
$170,823 | — | 31 Mar 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
0.13%
|
27,274
|
$160,917 | — | 31 Mar 2025 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.11%
|
23,020
|
$135,818 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.11%
|
22,725
|
$134,078 | — | 31 Mar 2025 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.1%
|
21,710
|
$128,089 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
21,473
|
$126,691 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
18,599
|
$109,734 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
17,259
|
$101,828 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
17,038
|
$100,524 | — | 31 Mar 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.07%
|
15,149
|
$89,379 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.07%
|
14,612
|
$86,204 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
14,193
|
$83,739 | — | 31 Mar 2025 | |
| TITLEIST ASSET MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
12,900
|
$76,110 | — | 31 Mar 2025 | |
| Creative Planning |
13F
|
Company |
0.06%
|
11,764
|
$69,408 | — | 31 Mar 2025 | |
| Allegiance Financial Group Advisory Services LLC |
13F
|
Company |
0.05%
|
10,000
|
$59,000 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
4,772
|
$28,000 | — | 31 Mar 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
300
|
$1,770 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
250
|
$1,000 | — | 31 Mar 2025 | |
| PRIVATE TRUST CO NA |
13F
|
Company |
0%
|
100
|
$590 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
86
|
$507 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
2
|
$13 | — | 31 Mar 2025 |
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q2 2025
As of 30 Jun 2025,
Journey Medical Corp - Common Stock (DERM) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,494,302 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, WASATCH ADVISORS LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, AMERICAN FINANCIAL GROUP INC, UBS Group AG, and PVG ASSET MANAGEMENT CORP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
38
Q2 2025 holders
56
Holder diff
18
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.